DocCheck AG
ANWGN.DE operates in the healthcare sector, specializing in biotechnology and providing healthcare facilities and services, generating revenue primarily through its operations in this field.
Business. ANWGN.DE is a healthcare company operating within the Healthcare Facilities & Services industry, with a primary focus on biotechnology activities. The firm generates revenue through service-based models typical of the healthcare services sector. It is headquartered in Germany and is listed on the Xetra exchange under the ticker ANWGN.DE. Specific details regarding operating segments and geographic breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ANWGN.DE is a healthcare company operating within the Healthcare Facilities & Services industry, with a primary focus on biotechnology activities. The firm generates revenue through service-based models typical of the healthcare services sector. It is headquartered in Germany and is listed on the Xetra exchange under the ticker ANWGN.DE. Specific details regarding operating segments and geographic breakdowns are not available.
ANWGN.DE maintains a strong liquidity position, with a current ratio of 3.18, indicating the company can easily cover its short-term liabilities with its short-term assets. The company holds EUR 14,479,820 in cash and equivalents, which is a significant portion of its total assets of EUR 55,675,040. The debt-to-equity ratio of 0.1 suggests a conservative capital structure with minimal reliance on debt financing.
In terms of profitability, ANWGN.DE reports a return on equity (ROE) of 12.82% and a return on assets (ROA) of 9.58%, both of which are strong indicators of efficient use of equity and assets. The company's operating income of EUR 8,166,020 and net income of EUR 5,334,220 reflect solid performance relative to its revenue of EUR 55,315,410. These metrics align with the industry's preferred focus on ROE and ROA as key performance indicators.
ANWGN.DE's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of segment and geographic detail limits the ability to assess exposure to specific markets or product lines.
The company's growth trajectory is not explicitly outlined in the available data, but its operating cash flow of EUR 5,978,830 and free cash flow of EUR 608,640 suggest a capacity to fund operations and potentially invest in future growth. The capital expenditure of EUR -3,741,180 indicates a reduction in capital spending, which may reflect a strategic shift or a focus on cost efficiency.
ANWGN.DE presents a low risk of dilution, with no immediate filing-based liquidity or dilution flags detected. The company's conservative capital structure and strong liquidity position reduce the likelihood of near-term equity issuance to fund operations or debt obligations.
No recent events, such as filings or transcripts, are available in the provided data to inform the company's current strategic direction or operational developments. The absence of such information limits the ability to assess the impact of recent business decisions or external factors on the company's performance.
- ANWGN.DE has a strong liquidity position with a current ratio of 3.18 and significant cash reserves.
- The company demonstrates solid profitability with a ROE of 12.82% and ROA of 9.58%.
- ANWGN.DE maintains a conservative capital structure with a low debt-to-equity ratio of 0.1.
- The company's financials do not provide detailed segment or geographic revenue breakdowns.
- There is no immediate risk of dilution or liquidity pressure based on the available data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ANWGN.DE Market data — financials · 2026-05-27
Ownership & reference
Leadership
- Joachim PietzkoChairman of the Supervisory Board